[논문]Matrix metalloproteinase 3 as a valuable marker for patients with COVID‐19

Shi, Shengjie; Su, Min; Shen, Ge; Hu, Yan; Yi, Fan; Zeng, Ziyan; Zhu, Pan; Yang, Gang; Zhou, Hui; Li, Qiong; Xie, Xiaobing

doi:10.1002/jmv.26235

Matrix metalloproteinase 3 as a valuable marker for patients with COVID‐19 원문보기

Journal of medical virology, v.93 no.1, 2021년, pp.528 - 532

Shi, Shengjie (Hunan University of Chinese Medicine, Changsha, Hunan, China) , Su, Min (Department of Medical Laboratory and Pathology Center, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China) , Shen, Ge (Loudi Center for Diseases Prevention and Control, Loudi, Hunan, China) , Hu, Yan (Department of Medical Laboratory and Pathology Center, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China) , Yi, Fan (Hunan University of Chinese Medicine, Changsha, Hunan, China) , Zeng, Ziyan (Loudi Center for Diseases Prevention and Control, Loudi, Hunan, China) , Zhu, Pan (Loudi Center for Diseases Prevention and Control, Loudi, Hunan, China) , Yang, Gang (Loudi Center for Diseases Prevention and Control, Loudi, Hunan, China) , Zhou, Hui (De) , Li, Qiong , Xie, Xiaobing

Abstract ▼ AI-Helper

AbstractThe situation of the coronavirus disease 2019 (COVID‐19) continues to evolve, our study explored the significance of serum levels of matrix metalloproteinase 3 (MMP3) as a marker for patients with COVID‐19. Sixty‐two COVID‐19 patients in the First Hospital of Hunan University of Chinese Medicine and Loudi Center for Diseases Prevention and Control, from January to March 2020, were sampled as the novel coronavirus pneumonia infected group. One hundred and thirty‐one cases from the First Hospital of Hunan University of Chinese Medicine, including 67 healthy individuals and 64 non‐COVID‐19 inpatients, served as the noninfected group. Approximately every 5 days, sera from 20 cases were collected and analyzed three times, using an automatic biochemical analyzer, to detect serum MMP3 concentrations. Correlation was analyzed between MMP3 and other proinflammatory cytokines. Following normality tests, differences in serum MMP3 levels between the infected and noninfected group were analyzed via SPSS (version 25.0) software, using the Wilcoxon rank sum test. The MMP3 concentration was 44.44 (23.46 ~ 72.12) ng/mL in the infected group and 32.42 (28.16 ~ 41.21) ng/mL in the noninfected group. The difference between the two groups was statistically significant (Z = −2.799, P = .005 < .05). A positive correlation was found between MMP3 and interleukin 1β (IL‐1β; r = .681, P = .000 < .05), and IL‐6 (r = .529, P = .002 < .05). Serum MMP3 concentration, measured over three separate time points, were 55.98 (30.80 ~ 75.97) ng/mL, 34.84 (0.00 ~ 51.84) ng/mL, and 5.71 (0.00 ~ 40.46) ng/mL, respectively. Detection of serum MMP3 levels may play an important role in the development of therapeutic approaches for COVID‐19 and may indicate the severity of disease.

주제어

참고문헌 (21)

1 Chan JF , Yuan S , Kok KH , et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person‐to‐person transmission: a study of a family cluster . Lancet . 2020 ; 395 ( 10223 ): 514 ‐ 523 . 10.1016/S0140-6736(20)30154-9 31986261

상세보기
2 Guo YR , Cao QD , Hong ZS , et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID‐19) outbreak—an update on the status . Mil Med Res . 2020 ; 7 ( 1 ): 11 . 10.1186/s40779-020-00240-0 32169119

상세보기
3 Li Z , Yi Y , Luo X , et al. Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis . J Med Virol . 2020 . 10.1002/jmv.25727

상세보기
4 Yi F , Chen JL , Su M , et al. Clinical value of differential diagnosis of matrix metalloproteinase‐3 in benign and malignant hydrothorax and ascites . Chin J Lab Med . 2019 ; 09 : 776 ‐ 781 .
5 Nissinen L , Kähäri VM . Matrix metalloproteinases in inflammation . Biochim Biophys Acta . 2014 ; 1840 ( 8 ): 2571 ‐ 2580 . 10.1016/j.bbagen.2014.03.007 24631662

상세보기
6 McCawley LJ , Matrisian LM . Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol . 2001 ; 13 ( 5 ): 534 ‐ 540 . 10.1016/s0955-0674(00)00248-9 11544020

상세보기
7 Lerner A , Neidhöfer S , Reuter S , Matthias T . MMP3 is a reliable marker for disease activity, radiological monitoring, disease outcome predictability, and therapeutic response in rheumatoid arthritis . Best Pract Res Clin Rheumatol . 2018 ; 32 ( 4 ): 550 ‐ 562 . 10.1016/j.berh.2019.01.006 31174824

상세보기
8 Hattori Y , Kida D , Kaneko A . Normal serum matrix metalloproteinase‐3 levels can be used to predict clinical remission and normal physical function in patients with rheumatoid arthritis . Clin Rheumatol . 2019 ; 38 ( 1 ): 181 ‐ 187 . 10.1007/s10067-017-3829-9 28940139

상세보기
9 Davey A , McAuley DF , O'Kane CM . Matrix metalloproteinases in acute lung injury: mediators of injury and drivers of repair . Eur Respir J . 2011 ; 38 ( 4 ): 959 ‐ 970 . 10.1183/09031936.00032111 21565917

상세보기
10 General Office of National Health Commission of the People's Republic of China, Office of National Administration of Traditional Chinese Medicine. Diagnosis and treatment of corona virus disease‐19 (7th trial edition). https://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml
11 Nerusu KC , Warner RL , Bhagavathula N , McClintock SD , Johnson KJ , Varani J . Matrix metalloproteinase‐3 (stromelysin‐1) in acute inflammatory tissue injury . Exp Mol Pathol . 2007 ; 83 ( 2 ): 169 ‐ 176 . 10.1016/j.yexmp.2007.04.003 17540368

상세보기
12 Warner RL , Beltran L , Younkin EM , et al. Role of stromelysin 1 and gelatinase B in experimental acute lung injury . Am J Respir Cell Mol Biol . 2001 ; 24 ( 5 ): 537 ‐ 544 . 10.1165/ajrcmb.24.5.4160 11350822

상세보기
13 Yamashita CM , Cybulskie C , Milos S , Zuo YY , McCaig LA , Veldhuizen RA . The effect of matrix metalloproteinase‐3 deficiency on pulmonary surfactant in a mouse model of acute lung injury . Can J Physiol Pharmacol . 2016 ; 94 ( 6 ): 682 ‐ 685 . 10.1139/cjpp-2015-0377 27096327

상세보기
14 Warner RL , Bhagavathula N , Nerusu KC , et al. Matrix metalloproteinases in acute inflammation: induction of MMP‐3 and MMP‐9 in fibroblasts and epithelial cells following exposure to pro‐inflammatory mediators in vitro . Exp Mol Pathol . 2004 ; 76 ( 3 ): 189 ‐ 195 . 10.1016/j.yexmp.2004.01.003 15126100

상세보기
15 Nissinen L , Kähäri VM . Matrix metalloproteinases in inflammation . Biochim Biophys Acta . 2014 ; 1840 ( 8 ): 2571 ‐ 2580 . 10.1016/j.bbagen.2014.03.007 24631662

상세보기
16 Xu Z , Shi L , Wang Y , et al. Pathological findings of COVID‐19 associated with acute respiratory distress syndrome . Lancet Respir Med. 2020 ; 8 ( 4 ): 420 ‐ 422 . 10.1016/S2213-2600(20)30076-X 32085846

상세보기
17 Huang C , Wang Y , Li X , et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China . Lancet . 2020 ; 395 ( 10223 ): 497 ‐ 506 . 10.1016/S0140-6736(20)30183-5 31986264

상세보기
18 Zhang Y , Yu L , Tang L , et al. A promising anti‐cytokine‐storm targeted therapy for COVID‐19: the artificial‐liver blood‐purification system . Engineering . 2020 . 10.1016/j.eng.2020.03.006

상세보기
19 Chen G , Wu D , Guo W , et al. Clinical and immunological features of severe and moderate coronavirus disease 2019 . J Clin Invest . 2020 ; 130 : 137244 ‐ 2629 . 10.1172/JCI137244 32217835

상세보기
20 Hoffmann M , Kleine‐Weber H , Schroeder S , et al. SARS‐CoV‐2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor . Cell . 2020 ; 181 ( 2 ): 271 ‐ 280 . 10.1016/j.cell.2020.02.052 32142651

상세보기
21 Phillips JM , Gallagher T , Weiss SR . Neurovirulent murine coronavirus JHM.SD uses cellular zinc metalloproteases for virus entry and cell‐cell fusion . J Virol . 2017 ; 91 ( 8 ): e01564‐16 . 10.1128/JVI.01564-16 28148786

상세보기

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증

Matrix metalloproteinase 3 as a valuable marker for patients with COVID‐19 원문보기

Abstract ▼ AI-Helper

주제어

참고문헌 (21)

이 논문을 인용한 문헌

관련 콘텐츠

원문 보기

원문 URL 링크

오픈액세스(OA) 유형

이 논문과 함께 이용한 콘텐츠

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트